Pharmacology of INS37217 [P(1)-(uridine 5′)-P(4)-(2′-deoxycytidine 5′) tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis - Yerxa,B.R.; Sabater,J.R.; Davis,C.W. (J Pharmacol Exp Ther, 2002)